The device generates nitric oxide gas utilizing the company’s proprietary nitric oxide generating tablets.
Clark Mower, chairman of the board of GeNOsys, said: “The unique design of this single-use generator provides a very cost-effective solution to a number of treatment applications. We will identify those applications where it can be used most effectively upon receipt of FDA approval and then work to broaden its application and use to other areas.”